Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATF3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ATF3 is an entity related to neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 242 entities in the SciDEX knowledge graph.
Knowledge base pages for this entity
graph TD
ATF3["ATF3"] -->|"regulates"| TREM2["TREM2"]
ATF3["ATF3"] -->|"exacerbates"| neurodegeneration["neurodegeneration"]
ATF3["ATF3"] -->|"activates"| Aging["Aging"]
ATF3["ATF3"] -->|"activates"| Cardiovascular["Cardiovascular"]
ATF3["ATF3"] -->|"activates"| Fibrosis["Fibrosis"]
ATF3["ATF3"] -->|"therapeutic target"| Fibrosis_1["Fibrosis"]
MYO7A["MYO7A"] -->|"activates"| ATF3["ATF3"]
MAP1LC3B["MAP1LC3B"] -->|"activates"| ATF3["ATF3"]
OPTN["OPTN"] -->|"activates"| ATF3["ATF3"]
PARKIN["PARKIN"] -->|"activates"| ATF3["ATF3"]
style ATF3 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 0.85 |
| Fibrosis | activates | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Colorectal Cancer | therapeutic_target | disease | 0.75 |
| Ferroptosis | activates | pathway | 0.70 |
| NF-kB signaling | participates_in | pathway | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| Aging | activates | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Prostate Cancer | therapeutic_target | disease | 0.65 |
| Infection | therapeutic_target | disease | 0.65 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.65 |
| Liver Cancer | therapeutic_target | disease | 0.65 |
| Pulmonary Fibrosis | therapeutic_target | disease | 0.65 |
| Lung Cancer | therapeutic_target | disease | 0.65 |
| Pancreatic Cancer | therapeutic_target | disease | 0.65 |
| Gastric Cancer | therapeutic_target | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Metabolic Syndrome | activates | disease | 0.65 |
| Hepatitis | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Glaucoma | regulates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GENES | activates | gene | 0.70 |
| FERROPTOSIS | activates | gene | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| MYO7A | activates | gene | 0.60 |
| MAP1LC3B | activates | gene | 0.60 |
| OPTN | activates | gene | 0.60 |
| PARKIN | activates | gene | 0.60 |
| PINK1 | activates | gene | 0.60 |
| XBP1 | activates | gene | 0.60 |
| PTEN | activates | gene | 0.60 |
| USP30 | activates | gene | 0.60 |
| FOXO3 | activates | gene | 0.60 |
| MBP | activates | gene | 0.60 |
| FGF20 | therapeutic_target | gene | 0.60 |
| BRG1 | therapeutic_target | gene | 0.60 |
| NRCAM | therapeutic_target | gene | 0.60 |
| NOTCH2 | therapeutic_target | gene | 0.60 |
| EP300 | therapeutic_target | gene | 0.60 |
| CTNNB1 | therapeutic_target | gene | 0.60 |
| NEUROD1 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| VEGFA | therapeutic_target | gene | 0.60 |
| ABCB1 | therapeutic_target | gene | 0.60 |
| FOXM1 | therapeutic_target | gene | 0.60 |
| LEF1 | therapeutic_target | gene | 0.60 |
| SMARCA4 | therapeutic_target | gene | 0.60 |
| TERT | therapeutic_target | gene | 0.60 |
| FZD7 | therapeutic_target | gene | 0.60 |
| JAG1 | therapeutic_target | gene | 0.60 |
| MITF | therapeutic_target | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| AXIN2 | therapeutic_target | gene | 0.60 |
| CD44 | therapeutic_target | gene | 0.60 |
| ALDH1A1 | therapeutic_target | gene | 0.60 |
| FGF18 | therapeutic_target | gene | 0.60 |
| ELAVL1 | activates | gene | 0.60 |
| TP53 | regulates | gene | 0.60 |
| UBIQUITIN | regulates | gene | 0.60 |
| CLDN1 | therapeutic_target | gene | 0.60 |
| AXIN1 | therapeutic_target | gene | 0.60 |
| PPARD | therapeutic_target | gene | 0.60 |
| APC | therapeutic_target | gene | 0.60 |
| CREBBP | therapeutic_target | gene | 0.60 |
| PTGS2 | therapeutic_target | gene | 0.60 |
| DKK1 | therapeutic_target | gene | 0.60 |
| IL10 | therapeutic_target | gene | 0.60 |
| ANXA2 | activates | gene | 0.60 |
| ICAM1 | activates | gene | 0.60 |
| CD44 | activates | gene | 0.60 |
| HMOX1 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||